TRENDING :  Market Movers  |  Top 50   SPY (0.37%)    BA (-1.78%)    WTRH (-0.37%)    VXXB (0.25%)    UNIT (-0.32%)    UAA (0.64%)    TVIX (0.08%)    TJX (1.13%)    ASHS (2.11%)    AKTX (12.01%)    ADBE (0.27%)    ACHV (5.32%)    AAT (-0.05%)    SIRI (-1.79%)    SBGI (-2.07%)    ROKU (1.31%)    MMYT (-1.63%)    LRN (-1.49%)    KSU (1.37%)    JMU (4.35%)    JBLU (-0.66%)    GLBS (-17.98%)    DIS (-1.61%)    CDNA (0.74%)    BRS (0%)

 AKBA - Akebia Therapeutics

$8.17 [0][0%]




Trade Idea »


No recommendations found.

This list is limited to recommendations made in last 7 days only. Subscribe to a service to see all their recommendations.


Service NameTrader% Success
Alpha Swing TradesJonathan69.00 %Follow


Why Akebia Therapeutics, Momo, and Switch Jumped Today

The stock market generally kept gaining ground on Tuesday with only downward pressure from the most heavily weighted component of the Dow Jones Industrial Average preventing a clean sweep of every major benchmark posting solid gains Investors have been pleased overall with the

Why Akebia Therapeutics Is Soaring Today

What happened Shares of Akebia Therapeutics NASDAQ AKBA were soaring 14 9 higher as of 10 53 a m EDT on Tuesday The biopharmaceutical company announced positive results earlier in the day from two phase 3 clinical studies evaluating vadadustat 160 in treating anemia due

Health Care Sector Update for 03/12/2019: ZFGN, AKBA, HEXO, JNJ, PFE, ABT, MRK, AMGN

Top Health Care Stocks Top Health Care Stocks JNJ 0 20 JNJ 0 20 PFE 0 19 PFE 0 19 ABT FlatABT Flat MRK FlatMRK Flat AMGN FlatAMGN Flat Leading health care stocks were mixed in Tuesday s pre market trading Leading health care stocks were mixed in Tuesday spre market

Pre-Market Most Active for Mar 12, 2019 : AKBA, MOMO, SQQQ, NIO, SFIX, ERIC, TVIX, BA, DKS, NM, ADT, ACB

The NASDAQ 100 Pre Market Indicator is up 10 39 to 7 174 41 The total Pre Market volume is currently 5 088 827 shares traded The following are the most active stocks for the pre market session Akebia Therapeutics Inc AKBA is 1 44 at 8 78 with 735 198

Analysts Estimate Akebia Therapeutics (AKBA) to Report a Decline in Earnings: What to Look Out for

Akebia Therapeutics AKBA is expected to deliver a year over year decline in earnings on lower revenues when i t report s results for the quarter ended December 2018 This widely known consensus outlook gives a good sense of the company s earnings picture but how the actual results compare